# Safety Study of BLZ-100 in Adult Subjects With Sarcoma Undergoing Surgery

Source: https://onco.cc/trials/nct02464332/  
OnCo record `nct02464332` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 1 trial of Tozuleristide run by Blaze Bioscience Inc., withdrawn before enrolling.

## Summary

Safety Study of BLZ-100 in Adult Subjects With Sarcoma Undergoing Surgery is a phase 1 interventional study registered as NCT02464332 by Blaze Bioscience Inc., started 2015-09. Conditions recorded: Sarcoma, Soft Tissue. Interventions recorded: BLZ-100.

## Fields

- Kind: Trial
- Status: withdrawn
- Last checked: 2026-11-03
- Tags: pipeline; ctgov-ingest
- Registry id: NCT02464332
- Phase: 1
- Setting: A Phase 1 Study of BLZ-100 Administered by Intravenous Injection in Subjects With Soft Tissue Sarcoma Undergoing Surgery
- Sponsor: Blaze Bioscience Inc.

## Sources

- ClinicalTrials.gov NCT02464332: https://clinicaltrials.gov/study/NCT02464332

## Connected records

- cancers: [Sarcomas (soft tissue, bone, GIST)](https://onco.cc/cancers/sarcoma/)
- drugs: [Tozuleristide](https://onco.cc/drugs/blz-100/)
- companies: [Blaze Bioscience](https://onco.cc/companies/blaze-bioscience/)

---
JSON: https://onco.cc/api/v1/entities/nct02464332.json